To date, it has been reported that Trop-2 is highly expressed in various types of solid tumors, such as ovarian [10], cervical [11,12], colorectal [13,14], gastric [15], pancreatic [16], and breast cancers [17]. Here, TACSTD2 is linked to breast cancer.